TeraWulf
WULF
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
Bitfarms
BITF
CleanSpark
CLSK
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.